Generic drug sales increased 20 percent and sales of the anesthetic Lidoderm increased 16 percent. Stocks ended at $1.27 per share, above expectations of $1.18 per share.
Lower expectations were due in part to two patent lawsuit settlements.
More Articles on Anesthesia:
First Grad Completes TeamHealth Anesthesia Management Fellowship
Colorado Court Says CRNAs Can Administer Anesthesia
Somnia Releases White Paper on Anesthesia’s Role in Perioperative Management
Register to Attend Webinar
Presenters:
Dr. Jennifer Weinberg, R1|Melissa Hannan, R1
Next Up in Financial Management
-
Average private health insurance premiums rose 78.4% from 2011 to 2024, and growth in healthcare spending accounted for 91% of…
-
Here are 24 health systems that have made revenue cycle vice president hires in 2026: 1. Chicago-based CommonSpirit Julie Morgan…
-
Top C-suite executives didn’t get there by accident. The most successful leaders earned the role by building relationships, listening to…
Join the 500,000+ healthcare executives who start their day with Becker's
Becker's Hospital Review Newsletter is sent Monday–Sunday.
